Poster Display session Poster Display session

47P - Quality of life after extended pelvic exenterations

Presentation Number
47P
Lecture Time
16:05 - 16:10
Speakers
  • David Cibula (Prague, Czech Republic)
Session Name
Room
Exhibition area
Date
Fri, 17.06.2022
Time
12:15 - 13:00

Abstract

Background

While traditional pelvic exenterations (PE) represent a potentially curative treatment for recurrent tumours localized centrally in the pelvis, new surgical techniques have been developed recently to enable a complete resection even in tumours invading into the pelvic side wall. Extended pelvic exenterations (EPE) include resection of internal, external, or common iliac vessels, pelvic side-wall muscles, large pelvic nerves, or pelvic bones. EPE are currently performed only in a few institutions and data on treatment morbidity are not available. The aim of the study was to compare health-related quality of life (QoL) and oncological outcome after PE and EPE.

Methods

Data from 72 patients with cervical (36), vulvar (19), endometrial (14) and low-grade ovarian (5) cancer who underwent PE (42) or EPE (32) for persistent (20%) or recurrent (80%) disease between 2014 to 2019 at a single tertiary centre were analysed. Quality of life was evaluated in surviving patients using EORTC QLQ-C30, EORTC CX-24, and QOLPEX questionnaire developed specifically for patients after extensive pelvic procedures.

Results

Median overall and disease-specific survival reached in the whole cohort 45 and 49 months, without significant differences between PE and EPE groups (P >0.999). We did not observe any difference in post-surgical complication types or frequency between the groups. Thirty-one survivors participated in the QoL assessment (20 PE, 11 EPE) and no significant differences were found in global health status (P=0.951) or in any of the functional scales. The groups were not differing in therapy satisfaction (P=0.502), and both expressed similar willingness to potentially undergo treatment again (P=0.317) (Table).

EORTC QLQ 30, EORTC QLQ-CX24 – Main results

Pelvic exenteration Extended pelvic exenteration
Valid (missing) Mean (SD) Valid (missing) Mean (SD) P-value
Functional scales (higher value = better functioning)
Global health status 20 62.9 (19.75) 11 64.5 (21.36) 0.951
Physical functioning 20 67.2 (23.92) 11 73.0 (19.62) 0.583
Role functioning 20 57.8 (40.28) 11 60.9 (31.84) 0.951
Emotional functioning 20 75.2 (20.64) 11 81.2 (18.34) 0.427
Cognitive functioning 20 87.8 (16.78) 11 82.3 (11.60) 0.157
Therapy assessment (higher value = higher satisfaction)
Would undergo again 20 83.8 (28.42) 11 72.7 (28.40) 0.317
Therapy satisfaction 20 90.0 (18.85) 11 86.36 (17.19) 0.502

SD, standard deviation.

Conclusions

EPE are associated with similar post-treatment QoL and survival as traditional PE. These procedures represent potentially curative treatment option for patients with persistent or recurrent pelvic cancer invading into pelvic wall structures without further compromising QoL.

Legal entity responsible for the study

The authors.

Funding

Charles University in Prague (UNCE 204065 and PROGRES Q28/LF1).

Disclosure

All authors have declared no conflicts of interest.

Collapse